These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19347734)

  • 1. Overexpression of the Fas-inhibitory molecule TOSO: a novel antiapoptotic factor in chronic lymphocytic leukemia.
    Pallasch CP; Wendtner CM
    Leuk Lymphoma; 2009 Mar; 50(3):498-501. PubMed ID: 19347734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease.
    Pallasch CP; Schulz A; Kutsch N; Schwamb J; Hagist S; Kashkar H; Ultsch A; Wickenhauser C; Hallek M; Wendtner CM
    Blood; 2008 Nov; 112(10):4213-9. PubMed ID: 18708628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TOSO interacts with SYK and enhances BCR pathway activation in chronic lymphocytic leukemia.
    Zhang YR; Yu Z; Xiong WJ; Liu XX; Liu HM; Cui R; Wang Q; Chen WM; Qiu LG; Yi SH
    Chin Med J (Engl); 2020 Sep; 133(17):2090-2097. PubMed ID: 32784334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAGE analysis demonstrates increased expression of TOSO contributing to Fas-mediated resistance in CLL.
    Proto-Siqueira R; Panepucci RA; Careta FP; Lee A; Clear A; Morris K; Owen C; Rizzatti EG; Silva WA; Falcão RP; Zago MA; Gribben JG
    Blood; 2008 Jul; 112(2):394-7. PubMed ID: 18434611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and prognostic significance of TOSO in CD19+ B cells from Chinese CLL patients].
    Yu Z; Zhou KS; Li ZJ; Yi SH; Hao M; Li CH; Qi JY; Qiu LG
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1371-4. PubMed ID: 21756805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOSO is overexpressed and correlated with disease progression in Chinese patients with chronic lymphocytic leukemia.
    Yi S; Yu Z; Zhou K; Wang Y; An G; Li Z; Zou D; Qi J; Zhao Y; Chan WC; Qiu L
    Leuk Lymphoma; 2011 Jan; 52(1):72-8. PubMed ID: 21133733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Fc mu receptor (FCMR, TOSO) gene in chronic lymphocytic leukemia patients.
    Hancer VS; Diz-Kucukkaya R; Aktan M
    Med Oncol; 2012 Jun; 29(2):1068-72. PubMed ID: 21264533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
    Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toso regulates the balance between apoptotic and nonapoptotic death receptor signaling by facilitating RIP1 ubiquitination.
    Nguyen XH; Lang PA; Lang KS; Adam D; Fattakhova G; Föger N; Kamal MA; Prilla P; Mathieu S; Wagner C; Mak T; Chan AC; Lee KH
    Blood; 2011 Jul; 118(3):598-608. PubMed ID: 21613257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia.
    Humphries LA; Godbersen JC; Danilova OV; Kaur P; Christensen BC; Danilov AV
    Br J Haematol; 2013 Dec; 163(5):590-602. PubMed ID: 24117128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD25 blockade protects T cells from activation-induced cell death (AICD) via maintenance of TOSO expression.
    Richter GH; Mollweide A; Hanewinkel K; Zobywalski C; Burdach S
    Scand J Immunol; 2009 Sep; 70(3):206-15. PubMed ID: 19703010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells.
    Hitoshi Y; Lorens J; Kitada SI; Fisher J; LaBarge M; Ring HZ; Francke U; Reed JC; Kinoshita S; Nolan GP
    Immunity; 1998 Apr; 8(4):461-71. PubMed ID: 9586636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecules expression.
    de Totero D; Montera M; Rosso O; Clavio M; Balleari E; Foa R; Gobbi M
    Hematol J; 2004; 5(2):152-60. PubMed ID: 15048066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential gene expression profile associated to apoptosis induced by dexamethasone in CLL cells according to IGHV/ZAP-70 status.
    Baptista MJ; Muntañola A; Calpe E; Abrisqueta P; Salamero O; Fernández E; Codony C; Giné E; Kalko SG; Crespo M; Bosch F
    Clin Cancer Res; 2012 Nov; 18(21):5924-33. PubMed ID: 22966019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.
    Papakonstantinou N; Ntoufa S; Tsagiopoulou M; Moysiadis T; Bhoi S; Malousi A; Psomopoulos F; Mansouri L; Laidou S; Papazoglou D; Gounari M; Pasentsis K; Plevova K; Kuci-Emruli V; Duran-Ferrer M; Davis Z; Ek S; Rossi D; Gaidano G; Ritgen M; Oscier D; Stavroyianni N; Pospisilova S; Davi F; Ghia P; Hadzidimitriou A; Belessi C; Martin-Subero JI; Pott C; Rosenquist R; Stamatopoulos K
    Int J Cancer; 2019 Jun; 144(11):2695-2706. PubMed ID: 30447004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
    Rassenti LZ; Huynh L; Toy TL; Chen L; Keating MJ; Gribben JG; Neuberg DS; Flinn IW; Rai KR; Byrd JC; Kay NE; Greaves A; Weiss A; Kipps TJ
    N Engl J Med; 2004 Aug; 351(9):893-901. PubMed ID: 15329427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mouse cell surface protein TOSO regulates Fas/Fas ligand-induced apoptosis through its binding to Fas-associated death domain.
    Song Y; Jacob CO
    J Biol Chem; 2005 Mar; 280(10):9618-26. PubMed ID: 15632112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
    Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
    Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
    Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
    Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia.
    Kitada S; Zapata JM; Andreeff M; Reed JC
    Br J Haematol; 1999 Sep; 106(4):995-1004. PubMed ID: 10520003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.